Delivery Order SPE2DB20D2002-SPE2DB22FL04J
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,738.95 firm fixed-price delivery order is for the supply of 4,556,496,560 units of the pharmaceutical drug mirtazapine 30 mg tablets. The award has an ultimate completion date of March 9, 2022 and was made on March 8, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,556,431,955 units of the prescription medication mirtazapine 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,099.63 and a performance period through March 3, 2022. The contract was awarded on March 2, 2022 and did not have a set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mirtazapine 7.5 mg tablets. The $2,281.84 firm-fixed-price delivery order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award, valued at $1,074.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,567,027,264 units of the generic medication mirtazapine 15 mg tablets. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $3,212.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,528,079 units of 30 mg Mirtazapine tablets, a mental health treatment medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 25, 2024. This award is not associated with a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,144.24 Firm Fixed Price delivery order is for the supply of 4,554,483,108 units of Mirtazapine 30mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,480.83, is for the delivery of Mirtazapine 30 mg tablets in 1,000-count packages. The contract is a Firm Fixed Price Delivery Order that runs through January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
- This federal contract award, with ID SPE2DB20D1004|SPE2DB24FE9R2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,230.61 firm-fixed-price delivery order contract is for the supply of 4562953258 - Mirtazapine 7.5 mg tablets in 30-count packages. The contract has an ultimate completion date of December 1, 2023 and was awarded on November 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,799.02 Firm Fixed Price delivery order is for the supply of 4,566,514,987 units of Mirtazapine 7.5 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,204.44 firm fixed-price delivery order is for the supply of 4560449842 - Mirtazapine 7.5 mg tablets. The contract has an ultimate completion date of April 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL04JDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.26 firm fixed-price delivery order is for the supply of 4,555,552,160 units of Mirtazapine 15 mg tablets. The contract has an ultimate completion date of December 1, 2021 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/30/21 |